Table of Contents Author Guidelines Submit a Manuscript
Clinical Study
Journal of Obesity
Volume 2019, Article ID 6189724, 2 pages
https://doi.org/10.1155/2019/6189724
Erratum

Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”

1Analyze & Realize GmbH, Weißenseer Weg 111, 10369 Berlin, Germany
2Analyze & Realize GmbH, Waldseeweg 6, 13467 Berlin, Germany
3Zaluvida Corporate Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysia
4InQpharm Group Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysia

Correspondence should be addressed to Patricia De Costa; moc.mrahpqni@aicirtap

Received 8 May 2019; Accepted 12 May 2019; Published 11 July 2019

Copyright © 2019 Ralf Uebelhack et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

This article has no abstract.